Inhal Pharma Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
80
- Latest Deal Type
-
Series C
- Investors
-
13
Inhal Pharma General Information
Description
Developer of a dry powder inhalation platform designed to advance formulation development, inhaler design, and inhaled drug manufacturing. The company offers integrated development capabilities, a portfolio of inhaled health products, generic dry powder inhalers, and emerging inhaled therapeutics, enabling patients with respiratory and systemic conditions to access practical and effective inhaled treatments.
Contact Information
Website
www.inhalpharma.comCorporate Office
- Zhejiang Provincial New Materials Industry Innovation Complex
- Number 2660 Yongjiang Avenue
- Ningbo City, Zhejiang
- China
Corporate Office
- Zhejiang Provincial New Materials Industry Innovation Complex
- Number 2660 Yongjiang Avenue
- Ningbo City, Zhejiang
- China
Inhal Pharma Timeline
Inhal Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Later Stage VC (Series C) | 12-Mar-2026 | Completed | Generating Revenue | |||
| 11. Later Stage VC (Series B) | 31-Dec-2025 | Completed | Generating Revenue | |||
| 10. Later Stage VC (Series A2) | 26-Nov-2025 | Completed | Generating Revenue | |||
| 9. Later Stage VC | 04-Jul-2025 | Completed | Generating Revenue | |||
| 8. Early Stage VC (Series A1) | 12-Mar-2025 | Completed | Generating Revenue | |||
| 7. Secondary Transaction - Private | 08-Jul-2024 | Completed | Generating Revenue | |||
| 6. Secondary Transaction - Private | 26-Apr-2024 | Completed | Generating Revenue | |||
| 5. Early Stage VC | 23-Feb-2024 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series A) | 16-Oct-2023 | $6.88M | $8.41M | Completed | Generating Revenue | |
| 3. Secondary Transaction - Private | 18-Sep-2023 | $1.53M | Completed | Generating Revenue |
Inhal Pharma Patents
Inhal Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026099766-A1 | Continuous capsule inhalation device | Pending | 06-Nov-2024 | ||
| EP-4714433-A1 | Inhalation formulation for treating ipf disease and preparation method therefor | Pending | 07-Sep-2023 | ||
| US-20260083702-A1 | Inhalation formulation for treating ipf disease and preparation method therefor | Pending | 07-Sep-2023 | ||
| WO-2025051276-A1 | Inhalation formulation for treating ipf disease and preparation method therefor | Inactive | 07-Sep-2023 | ||
| US-11980859-B2 | Powder rotary fluidization device and method thereof | Active | 25-Aug-2022 | B01F33/405 |
Inhal Pharma Signals
Inhal Pharma Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Beijing State-owned Capital Operation and Management | Government | Minority | ||
| Sunz Fund | Venture Capital | Minority | ||
| Beijing Shunxi Private Equity Fund Management | Growth/Expansion | Minority | ||
| CBC Group (Singapore) | PE/Buyout | Minority | ||
| Zhangzhou Pien Tze Huang Investment Management | PE-Backed Company | Minority |
Inhal Pharma FAQs
-
When was Inhal Pharma founded?
Inhal Pharma was founded in 2020.
-
Where is Inhal Pharma headquartered?
Inhal Pharma is headquartered in Ningbo City, China.
-
What is the size of Inhal Pharma?
Inhal Pharma has 80 total employees.
-
What industry is Inhal Pharma in?
Inhal Pharma’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Inhal Pharma a private or public company?
Inhal Pharma is a Private company.
-
What is Inhal Pharma’s current revenue?
The current revenue for Inhal Pharma is .
-
How much funding has Inhal Pharma raised over time?
Inhal Pharma has raised $29.5M.
-
Who are Inhal Pharma’s investors?
Beijing State-owned Capital Operation and Management, Sunz Fund, Beijing Shunxi Private Equity Fund Management, CBC Group (Singapore), and Zhangzhou Pien Tze Huang Investment Management are 5 of 13 investors who have invested in Inhal Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process